ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,080,000 | -22.7% | 203,687 | -0.3% | 0.09% | -23.6% |
Q3 2016 | $2,691,000 | +3.7% | 204,351 | 0.0% | 0.12% | +7.0% |
Q2 2016 | $2,595,000 | -3.9% | 204,351 | 0.0% | 0.12% | +10.6% |
Q1 2016 | $2,699,000 | -41.0% | 204,351 | -31.3% | 0.10% | -29.7% |
Q4 2015 | $4,576,000 | +23.9% | 297,524 | -0.1% | 0.15% | +46.5% |
Q3 2015 | $3,692,000 | -56.2% | 297,717 | -51.7% | 0.10% | -52.4% |
Q2 2015 | $8,425,000 | +14.4% | 615,859 | 0.0% | 0.21% | +14.6% |
Q1 2015 | $7,366,000 | -6.3% | 615,859 | 0.0% | 0.18% | -6.6% |
Q4 2014 | $7,865,000 | -69.6% | 615,859 | -68.1% | 0.20% | -63.5% |
Q3 2014 | $25,902,000 | -20.3% | 1,930,793 | -4.7% | 0.54% | -13.4% |
Q2 2014 | $32,514,000 | +5.5% | 2,025,793 | +18.6% | 0.63% | +5.0% |
Q1 2014 | $30,808,000 | +29.8% | 1,708,718 | +11.3% | 0.60% | +37.2% |
Q4 2013 | $23,738,000 | +15.7% | 1,535,465 | +11.2% | 0.44% | +9.6% |
Q3 2013 | $20,524,000 | +40.2% | 1,380,244 | +22.0% | 0.40% | +38.3% |
Q2 2013 | $14,637,000 | – | 1,131,137 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |